Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)
CAPS Rating:
A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No one has written a Pitch for MNTA yet. Tell us why you think MNTA will outperform or underperform the market.
RSS Headlines
Fool UK
